Lee J, Han C, Lee D, Sung P, Bae S, Yang H
Gut Liver. 2024; 19(1):116-125.
PMID: 39639749
PMC: 11736320.
DOI: 10.5009/gnl240323.
Baek S, Yoon J
Biomolecules. 2024; 14(11).
PMID: 39595644
PMC: 11591830.
DOI: 10.3390/biom14111468.
Fang B, Luo J, Cui Z, Liu R, Wang P, Zhang J
Foods. 2024; 13(21).
PMID: 39517266
PMC: 11545291.
DOI: 10.3390/foods13213482.
Lee J, So J, Han C, Yang H, Sung P, Bae S
Hepatol Int. 2024; 19(1):181-190.
PMID: 39394385
DOI: 10.1007/s12072-024-10737-8.
Arulkumar R, Jin Jung H, Noh S, Kim H, Young Chung H
Int J Mol Sci. 2024; 25(17).
PMID: 39273677
PMC: 11395689.
DOI: 10.3390/ijms25179730.
The association of fatty liver index and metabolic syndrome with cardiovascular outcomes, liver-related mortality, and all-cause mortality: a nationwide cohort study.
Park S, Park J, Kim H, Lee J, Kwon S, Lee Y
Intern Emerg Med. 2024; 20(1):105-117.
PMID: 39235708
DOI: 10.1007/s11739-024-03758-6.
Impact of Korean Military Service on the Prevalence of Steatotic Liver Disease: A Longitudinal Study of Pre-enlistment and In-Service Health Check-Ups.
Lee J, Jung J, Choi S, Ha B, Yang H, Sung P
Gut Liver. 2024; 18(5):888-896.
PMID: 38953118
PMC: 11391135.
DOI: 10.5009/gnl240077.
Prevalence and Associated Factors of Liver Enzyme Abnormalities Among Bangladeshi Women: A Cross-Sectional Study.
Noor F, Shorovi N, Sarwar S, Fahima Ahmad T, Bahar N, Ashraf M
Cureus. 2024; 16(4):e57606.
PMID: 38707038
PMC: 11069394.
DOI: 10.7759/cureus.57606.
The additive effect of herbal medicines on lifestyle modification in the treatment of non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Kim M, Ahn S, Hur N, Oh S, Son C
Front Pharmacol. 2024; 15:1362391.
PMID: 38464716
PMC: 10920213.
DOI: 10.3389/fphar.2024.1362391.
Mobile App-Based Lifestyle Coaching Intervention for Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial.
Kwon O, Lee M, Lee H, Kim H, Lee J, Jang Y
J Med Internet Res. 2024; 26:e49839.
PMID: 38358794
PMC: 10905353.
DOI: 10.2196/49839.
Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome.
Friedman S
Diabetes Metab J. 2024; 48(2):161-169.
PMID: 38273792
PMC: 10995486.
DOI: 10.4093/dmj.2023.0240.
Development and Validation of a Risk Prediction Model for NAFLD: A Study Based on a Physical Examination Population.
Yang C, Du T, Zhao Y, Qian Y, Tang J, Li X
Diabetes Metab Syndr Obes. 2024; 17:143-155.
PMID: 38222035
PMC: 10785695.
DOI: 10.2147/DMSO.S438652.
The Clinical Diagnosis-Based Nationwide Epidemiology of Metabolic Dysfunction-Associated Liver Disease in Korea.
Lee N, Jeong S, Wang J, Choi Y, Oh H, Cho J
J Clin Med. 2023; 12(24).
PMID: 38137703
PMC: 10744038.
DOI: 10.3390/jcm12247634.
Muscle Mass Adjusted for Body Weight Is Associated with Significant Liver Fibrosis in Young Adults with Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study from a Korean Military Hospital.
Lee J, Na S, Kim T, Lee S, Kim M, Han C
J Obes Metab Syndr. 2023; 32(3):279-283.
PMID: 37661093
PMC: 10583765.
DOI: 10.7570/jomes23035.
Gender Differences in the Risk for Incident Non-Alcoholic Fatty Liver Disease According to the Transition of Abdominal Obesity Status: A 16-Year Cohort Study.
Lee J, Jeon S, Lee H, Kwon Y
Nutrients. 2023; 15(13).
PMID: 37447207
PMC: 10346349.
DOI: 10.3390/nu15132880.
Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases.
Wang J
Biomedicines. 2023; 11(4).
PMID: 37189758
PMC: 10135662.
DOI: 10.3390/biomedicines11041140.
Ideal cardiovascular health metrics and the risk of nonalcoholic fatty liver disease in Korean adults.
Shim S, Jung S, Kim S, Kim H
Clin Hypertens. 2023; 29(1):3.
PMID: 36641485
PMC: 9840828.
DOI: 10.1186/s40885-022-00227-0.
Dietary patterns and risk of non-alcoholic fatty liver disease in Korean adults: a prospective cohort study.
Fu J, Shin S
BMJ Open. 2023; 13(1):e065198.
PMID: 36609321
PMC: 9827268.
DOI: 10.1136/bmjopen-2022-065198.
R. Br. Water Extract Ameliorates Hepatic Steatosis in a Non-Alcoholic Fatty Liver Disease Model by Regulating the AMPK Pathway.
Bae S, Lee Y, Lee J, Park J, Jun W
Nutrients. 2022; 14(24).
PMID: 36558538
PMC: 9780835.
DOI: 10.3390/nu14245379.
Association between severe hepatic steatosis examined by Fibroscan and the risk of high-risk colorectal neoplasia.
Kim K, Kang H, Yoo H, Jun Y, Lee H, Im J
PLoS One. 2022; 17(12):e0279242.
PMID: 36548355
PMC: 9778623.
DOI: 10.1371/journal.pone.0279242.